Fundraising FoxHighlight Capital — 2019 Investments
2 investments dated 2019 · listed companies and verified rows first · show all
Abogen Biosciences is a clinical-stage biotechnology company developing RNA-based medicines, with in-house capabilities spanning the full mRNA drug development cycle including protein engineering, mRNA sequence design and synthesis, lipid nanoparticle delivery, formulation, and commercial-scale manufacturing.
BiotechDeep TechHealthtech
Co-investors5Y CapitalCoatue ManagementQiming Venture PartnersSoftBank Vision FundBoyu CapitalGL Ventures+6 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.